Killer cell immunoglobulin-like receptor three domains short cytoplasmic tail 1 (KIR3DS1; CD158E2); killer cell immunoglobulin-like receptor three domains long cytoplasmic tail 1 (KIR3DL1; CD158E1); major histocompatibility complex class I B (HLA-B) BriefCommunication Pages: 822 - 822
Transforming growth factor-α (TGFA; TGFα); heparin-binding EGF-like growth factor (HBEGF) BriefCommunication Pages: 824 - 824
Ubiquitin associated and SH3 domain containing B (UBASH3B; TULA-2) BriefCommunication Pages: 825 - 825
Phospholipase A2 group IVA cytosolic, calcium-dependent (PLA2G4A; cPLA2-α) BriefCommunication Pages: 827 - 827
Microarray-based method for high-throughput analysis of CpG methylation BriefCommunication Pages: 838 - 838
DNA-binding domain containing retroviral vectors to improve specificity of genome integration BriefCommunication Pages: 840 - 840
Synthetic, α-galactosylceramide (α-GalCer)-based vaccine adjuvant BriefCommunication Pages: 841 - 841
Transplantable recellularized lung graft using decellularized lung matrix BriefCommunication Pages: 842 - 842
68Ga-based prostate-specific membrane antigen (PSMA; FOLH1; GCPII)-targeted imaging agents BriefCommunication Pages: 843 - 843
Complexity index in sarcomas (CINSARC) profile for predicting clinical outcome in cancer patients BriefCommunication Pages: 844 - 844
Disabled homolog 2 (DAB2) as a biomarker for squamous cell carcinoma (SCC) progression BriefCommunication Pages: 845 - 845
Apolipoprotein C-II (APOC2; APOCII) and serum amyloid A (SAA) as biomarkers of neonatal sepsis and necrotizing enterocolitis (NEC) infections BriefCommunication Pages: 846 - 846
